| Patent | Date |
|---|
Novel Il-17b Antibodies
App 20220281967 - BASTID; Jeremy ; et al. | 2022-09-08 |
Antibodies Having Specificity For Cd38 And Uses Thereof
App 20220251234 - Bensussan; Armand ; et al. | 2022-08-11 |
Novel Anti-cd25 Antibodies
App 20220251232 - OLIVE; Daniel ; et al. | 2022-08-11 |
Ex vivo generation of MHCII restricted CD4.sup.+ FOXP3.sup.+ regulatory T cells and therapeutic uses thereof
Grant 11,365,392 - Zagury , et al. June 21, 2 | 2022-06-21 |
Ex Vivo Generation Of Gamma Delta Foxp3+ Regulatory T Cells And Therapeutic Uses Thereof
App 20220119766 - ZAGURY; Daniel ; et al. | 2022-04-21 |
Non-human Animal Models Of Sezary Syndrome
App 20220087233 - MARIE-CARDINE; Anne ; et al. | 2022-03-24 |
Use Of Cd26 And Cd39 As New Phenotypic Markers For Assessing Maturation Of Foxp3+ T Cells And Uses Thereof For Diagnostic Purposes
App 20220018835 - ZAGURY; Daniel ; et al. | 2022-01-20 |
Ex vivo generation of .gamma..delta. Foxp3.sup.+ regulatory T cells and therapeutic uses thereof
Grant 11,198,851 - Zagury , et al. December 14, 2 | 2021-12-14 |
Monoclonal antibodies binding to the CD160 transmembrane isoform
Grant 11,186,635 - Bensussan , et al. November 30, 2 | 2021-11-30 |
Antibodies Against Human Cd39 And Use Thereof
App 20210261686 - Bensussan; Armand ; et al. | 2021-08-26 |
Antibodies Against Human Cd39 And Use Thereof For Inhibiting T Regulatory Cells Activity
App 20210032367 - Levy; Yves ; et al. | 2021-02-04 |
Antibodies against human CD39 and use thereof for inhibiting T regulatory cells activity
Grant 10,662,253 - Levy , et al. | 2020-05-26 |
Monoclonal Antibodies Binding To The Cd160 Transmembrane Isoform
App 20190256595 - BENSUSSAN; Armand ; et al. | 2019-08-22 |
Antagonists of IL-17 isoforms and their uses
Grant 10,351,623 - Alberici , et al. July 16, 2 | 2019-07-16 |
Immunotherapeutic Uses Of Ex Vivo Generated Foxp3+ Regulatory T Cells
App 20190167791 - ZAGURY; Daniel ; et al. | 2019-06-06 |
Ex Vivo Generation Of Gamma Delta Foxp3+ Regulatory T Cells And Therapeutic Uses Thereof
App 20190161729 - ZAGURY; Daniel ; et al. | 2019-05-30 |
Ex Vivo Generation Of Mhcii Restricted Cd4+foxp3+ Regulatory T Cells And Therapeutic Uses Thereof
App 20190161728 - ZAGURY; Daniel ; et al. | 2019-05-30 |
Combinations Therapies For The Treatment Of Cancer
App 20190151346 - AL-DACCAK; Reem ; et al. | 2019-05-23 |
Anti-CD160 specific antibodies for the treatment of eye disorders based on neoangiogenesis
Grant 10,208,124 - Le Bouteiller , et al. Feb | 2019-02-19 |
Kir3dl2 Is A Biomarker And A Therapeutic Target Useful For Respectively Preventing And Treating A Subset Of Cutaneous And Non-cutaneous Peripheral T-cell Lymphomas
App 20180291102 - GAULARD; Philippe ; et al. | 2018-10-11 |
Methods And Pharmaceutical Compositions For Enhancing Nk Cell Killing Activities
App 20180214550 - BENSUSSAN; Armand ; et al. | 2018-08-02 |
Antibodies Having Specificity To Myosin 18a And Uses Thereof
App 20180201687 - BENSUSSAN; Armand | 2018-07-19 |
Antagonists Of Il-17 Isoforms And Their Uses
App 20180066051 - Alberici; Gilles ; et al. | 2018-03-08 |
Antagonists of IL-17 isoforms and their uses
Grant 9,834,601 - Alberici , et al. December 5, 2 | 2017-12-05 |
Il-17 Antagonist Antibodies
App 20170233468 - ALBERICI; GILLES ; et al. | 2017-08-17 |
IL-17 antagonist antibodies
Grant 9,676,847 - Alberici , et al. June 13, 2 | 2017-06-13 |
Antibodies Against Human CD39 and Use Thereof for Inhibiting T Regulatory Cells Activity
App 20160137747 - Levy; Yves ; et al. | 2016-05-19 |
Kir3dl2 Is A Biomarker And A Therapeutic Target Useful For Respectively Preventing And Treating A Subset Of Cutaneous And Non-cutaneous Peripheral T-cell Lymphomas
App 20160130346 - GAULARD; Philippe ; et al. | 2016-05-12 |
Anti-cd160 Specific Antibodies For The Treatment Of Eye Disorders Based On Neoangiogenesis
App 20150344572 - Le Bouteiller; Philippe ; et al. | 2015-12-03 |
Anti-CD160 specific antibodies for the treatment of eye disorders based on neoangiogenesis
Grant 9,045,544 - Le Bouteiller , et al. June 2, 2 | 2015-06-02 |
Il-17 Antagonist Antibodies
App 20150104457 - Alberici; Gilles ; et al. | 2015-04-16 |
Antagonists Of Il-17 Isoforms And Their Uses
App 20150104456 - Alberici; Gilles ; et al. | 2015-04-16 |
Angiogenic and Immunologic Applications of Anti-CD160 Specific Compounds Obtainable From mAb CL1-R2
App 20150004170 - Bensussan; Armand ; et al. | 2015-01-01 |
ANGIOGENIC AND IMMUNOLOGIC APPLICATIONS OF ANTI-CD160 SPECIFIC COMPOUNDS OBTAINABLE FROM mAb CL1-R2
App 20140120110 - Bensussan; Armand ; et al. | 2014-05-01 |
Antibodies Against Human Cd39 And Use Thereof
App 20130273062 - Bensussan; Armand ; et al. | 2013-10-17 |
Means for the diagnosis and therapy of CTCL
Grant 8,518,655 - Bensussan , et al. August 27, 2 | 2013-08-27 |
Angiogenic and immunologic applications of anti-CD160 specific compounds obtainable from mAb CL1-R2
Grant 8,444,978 - Bensussan , et al. May 21, 2 | 2013-05-21 |
Anti-cd160 Specific Antibodies For The Treatment Of Eye Disorders Based On Neoangiogenesis
App 20130122006 - Le Bouteiller; Philippe ; et al. | 2013-05-16 |
Anti-CD71 monoclonal antibodies and uses thereof for treating malignant tumor cells
Grant 8,409,573 - Boumsell , et al. April 2, 2 | 2013-04-02 |
Novel Means For The Diagnosis And Therapy Of Ctcl
App 20120329063 - BENSUSSAN; ARMAND ; et al. | 2012-12-27 |
Methods For Diagnosis And Treatment Of Cutaneous T Cell Lymphomas
App 20120288499 - Bensussan; Armand ; et al. | 2012-11-15 |
Means for the diagnosis and therapy of CTCL
Grant 8,268,308 - Bensussan , et al. September 18, 2 | 2012-09-18 |
Use Of Anti-cd100 Antibodies
App 20120027758 - Belin; Marie-Francoise ; et al. | 2012-02-02 |
ANGIOGENIC AND IMMUNOLOGIC APPLICATIONS OF ANTI-CD160 SPECIFIC COMPOUNDS OBTAINABLE FROM mAb CL1-R2
App 20120003224 - Bensussan; Armand ; et al. | 2012-01-05 |
Anti-cd71 Monoclonal Antibodies and Uses Thereof for Treating Malignant Tumor Cells
App 20110311544 - Boumsell; Laurence ; et al. | 2011-12-22 |
Use of anti-CD100 antibodies for the treatment of inflammatory disorders affecting the central or peripheral nervous system
Grant 8,067,247 - Belin , et al. November 29, 2 | 2011-11-29 |
Novel Means For The Diagnosis And Therapy Of Ctcl
App 20110151472 - BENSUSSAN; ARMAND ; et al. | 2011-06-23 |
Means for the diagnosis and therapy of CTCL
Grant 7,919,085 - Bensussan , et al. April 5, 2 | 2011-04-05 |
Antibodies Against Human CD39 and Use Thereof for Inhibiting T Regulatory Cells Activity
App 20100303828 - Levy; Yves ; et al. | 2010-12-02 |
Identification Of New Isoforms Of The Mhc-class I Specific Receptor Cd160 And Uses Thereof
App 20100234294 - Bensussan; Armand ; et al. | 2010-09-16 |
Anti-CD71 monoclonal antibodies and uses thereof for treating malignant tumor cells
Grant 7,736,647 - Boumsell , et al. June 15, 2 | 2010-06-15 |
Nucleic acids encoding CD100 molecules
Grant 7,700,102 - Hall , et al. April 20, 2 | 2010-04-20 |
Use Of Soluble Cd160 To Suppress Immunity
App 20100008932 - Bensussan; Armand ; et al. | 2010-01-14 |
Angiogenic and immunoglobic applications of anti cd160 specific compounds obtainable from mab cl 1-r2
App 20090317401 - Bensussan; Armand ; et al. | 2009-12-24 |
Novel Means For The Diagnosis And Therapy Of Ctcl
App 20080274468 - Bensussan; Armand ; et al. | 2008-11-06 |
Means for the diagnosis and therapy of CTCL
Grant 7,399,595 - Bensussan , et al. July 15, 2 | 2008-07-15 |
Anti-CD71 monoclonal antibodies and uses thereof for treating malignant tumor cells
App 20060286030 - Boumsell; Laurence ; et al. | 2006-12-21 |
Use of anti-cd100 antibodies
App 20060233793 - Belin; Marie-Francoise ; et al. | 2006-10-19 |
Novel means for the diagnosis and therapy of ctcl
App 20050074761 - Bensussan, Armand ; et al. | 2005-04-07 |
| 